"Arkansas Urology is the state's premier urology practice, providing comprehensive treatment services to men and women of all ages. We provide our patients with the most effective, state-of-the-art procedures in a caring and compassionate atmosphere."

During the past decade, Arkansas Urology conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 4 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 2 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arkansas Urology" #1 sponsor was "Abbott" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Myriad Genetic Laboratories, Inc." with 3 trials sponsored, "ImmunityBio, Inc." with 2 trials sponsored and "UroGen Pharma Ltd." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arkansas Urology" #1 collaborator was "ClinLogix. LLC" with 2 trials as a collaborator, "AnchorDx Medical Co., Ltd." with 1 trials as a collaborator, "Carolina Urologic Research Center" with 1 trials as a collaborator and "Specialty Networks" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Arkansas Urology" are "Prostate Cancer" (8 trials), "Bladder Cancer" (4 trials), "Prostatic Neoplasms" (4 trials), "Non-muscle Invasive Bladder Cancer" (3 trials) and "Urothelial Carcinoma Bladder" (2 trials). Many other conditions were trialed in "Arkansas Urology" in a lesser frequency.

Most popular intervention types in "Arkansas Urology" are "Drug" (18 trials), "Device" (4 trials), "Diagnostic Test" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atrasentan" (3 trials), "Apalutamide" (2 trials), "Placebo" (2 trials), "Prednisone" (2 trials) and "Relugolix" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arkansas Urology" are 20 trials for "Male" genders and 8 trials for "All" genders.

Currently, there are NaN active trials in "Arkansas Urology". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Arkansas Urology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Arkansas Urology, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

Arkansas Urology has several departments that took part in Clinical trials: "Arkansas Urology Research Center" - 3 trials